Sentences with phrase «driving global market share»

Experienced, knowledgeable and savvy Project and Business Development executive with demonstrated track record of Domestic and International Project Management experience and superlative accomplishments in driving global market share, and business development, and revenue and profit growth.

Not exact matches

Shares of the world's biggest fast food chain by revenue rose more than 5 percent as global same - restaurant sales topped Wall Street forecasts, driven by the strength in mature markets especially the United Kingdom and Germany.

It's a science - driven company focused on solving problems like world hunger and global warming with, for instance, drought - resistance seeds, which have been gaining market share from competitors but had to be developed over years.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Uber's losses stem from its drive to win global market share at almost any cost.

Here, the team takes a look at the events driving global equity market action so far this year, and shares their value - oriented investment strategy in light of the conditions they currently see.

BMW i has a fine record of success: More than 100,000 vehicles with either pure - electric or plug - in hybrid drive systems from the BMW i, BMW iPerformance and MINI brands sold in 2017; BMW i among the global leaders in electric mobility; BMW Group tops the registration rankings for electrified vehicles in Europe with a market share of 21 per cent; BMW Group has a worldwide market share of 10 per cent and is also one of the global leaders; BMW i enjoys a standout position as a successful systems supplier and provider of mobility services across the electric mobility sphere.

The next - gen Countryman will also share its four - wheel drive system, an electronically controlled unit with the BMW X1, although some global markets will also get a cheaper FWD - only variant.

Here, the team takes a look at the events driving global equity market action so far this year, and shares their value - oriented investment strategy in light of the conditions they currently see.

Ricoh shares a common goal of being the most trusted brand with irresistible appeal in the global market by delivering excellence to improve people's workstyle and to drive sustainability.

Global marketing insights, analytics and strategy expert with 20 years of proven leadership for CPG and healthcare iicompanies, consistently delivering innovation in product and process, driving top - line and bottom - line growth and market share.

Results - driven marketing executive with proven success in building and leading a global marketing organization and the ability to plan, execute and measure a wide range of marketing strategies designed to build market share, revenue, profitability and positive brand awareness.

Career Profile: Top - producing Sales Professional with 15 + years of experience driving profit and market share growth for global pharmaceutical corporations.